Evidence map›Paper›PMID 41246004›Full record

ArticleInfection and drug resistance2025

First Report of

Jingjing Huang, Lijing Guo, Ge Zhang, Clement Kin Ming Tsui, Weichen Huang, Kuo Li, Xinyi Jin, Yali Liu, Xinfei Chen, Chaogui Tang and 2 more

Abstract read
In one paragraph

Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jingjing Huang *Department of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.
Lijing Guo *Department of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.ORCID 0009-0000-3059-8099
Ge Zhang *Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID 0009-0004-7730-7286
Clement Kin Ming TsuiInfectious Disease Research Laboratory, National Centre for Infectious Diseases, Singapore.
Weichen HuangDepartment of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.ORCID 0009-0008-8104-5046
Kuo LiDepartment of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.ORCID 0009-0007-7832-5162
Xinyi JinDepartment of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.ORCID 0009-0003-2572-4785
Yali LiuDepartment of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Xinfei ChenDepartment of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID 0000-0001-7701-357X
Chaogui TangDepartment of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.
Yingchun XuDepartment of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID 0000-0002-7126-9459
Ning LinDepartment of Clinical Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.ORCID 0000-0001-9573-7811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Two strains were isolated from skin wounds of immunocompromised patients. They were characterized based on colony morphology on Sabouraud dextrose agar, Gram staining, MALDI-TOF MS analysis, Erg11 amino acid sequences analysis, and phylogenetic analysis using combined sequences of 18S rDNA, D1/D2 domains, and ITS regions. Antifungal susceptibility testing was performed according to CLSI guidelines (M27-A3/M60). Results: The colonies transitioned from light yellow to orange within 48-96 h with Gram-positive budding cells. MALDI-TOF MS failed to identify accurately any of these strains. However, phylogenetic analysis of ITS confirmed that both strains were Conclusion: Our findings showed that

Indexed as

Cystobasidium slooffiaeRhodotorulaskin woundssuperficial infections

Identifiers

PMID41246004
PMCPMC12619543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.